A third dominant and critical immunosuppressive pathway relevant to brain tumors is mediated by CTLA-4, which simultaneously inhibits effector T cell activation/proliferation and Treg activation/function in GBM.18 This evidence concerns the gene CTLA4 and brain neoplasm.